Mobile Cardiac Telemetry (MCT) Study

NCT07158333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-11-12

No results posted yet for this study

Summary

This study will be a single center, single arm, open-label, prospective study to evaluate adhesive performance of the Bardy Diagnostics' (BardyDx) MCT Patch up to 30 days of wear.

Conditions

  • Healthy

Interventions

DEVICE

Mobile Cardiac Telemetry (MCT System)

MCT System without data transmission

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-05
Primary Completion
2025-09-12
Completion
2025-09-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07158333 on ClinicalTrials.gov